MoneyWorks4Me

Sharon Bio-Medicine informs outcome of board meeting

22 Jan 2013 Evaluate

Sharon Bio-Medicine has now informed that the board of directors at its meeting held on January 21, 2013, has resolved to convene an extra-ordinary general meeting to be held on February 16, 2013, for the approval of the shareholders on the said rollover of the existing FCCBs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1237.65
Cipla 1313.80
Lupin 1957.00
Zydus Lifesciences 1117.30
View more..